CKDXF (Opthea) Other Current Receivables : $5.99 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Opthea Other Current Receivables?

Opthea's Other Current Receivables for the quarter that ended in Dec. 2024 was $5.99 Mil.

Opthea's quarterly Other Current Receivables increased from Dec. 2023 ($5.29 Mil) to Jun. 2024 ($11.82 Mil) but then stayed the same from Jun. 2024 ($11.82 Mil) to Dec. 2024 ($5.99 Mil).

Opthea's annual Other Current Receivables increased from Jun. 2022 ($6.56 Mil) to Jun. 2023 ($6.56 Mil) and increased from Jun. 2023 ($6.56 Mil) to Jun. 2024 ($11.82 Mil).

Opthea Other Current Receivables Historical Data

The historical data trend for Opthea's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea Other Current Receivables Chart

Opthea Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Current Receivables

Get a 7-Day Free Trial

5.87

5.54

6.56

11.82

Opthea Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Receivables	Get a 7-Day Free Trial															8.34	6.56	5.29	11.82	5.99

Opthea Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Opthea Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Opthea's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (OTCPK:CKDXF) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

OPT:USA UKJ:Germany OPT:Australia

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.